Mumbai : Godrej Consumer Products Limited (GCPL), a leading emerging markets FMCG company, today announced its financial results for the quarter ended March 31, 2026.

FINANCIAL OVERVIEW

Q4 FY 2026 FINANCIAL PERFORMANCE SUMMARY:

  • Q4 FY 2026 consolidated sales grew by 11% year-on-year on the back of underlying volume growth of 6%,
  • Standalone business underlying volume grew by 8%, sales grew by 10% year-on-year
  • Indonesia sales grew by 3% year-on-year
  • Africa, USA, and Middle East sales grew 20% year-on-year
  • Q4 FY 2026 consolidated EBITDA* margins stood at 21.7%, growing 10% year-on-year.
  • Q4 FY 2026 consolidated net profit grew by 10% year-on-year (without exceptional items and one-offs)

FY 2026 FINANCIAL PERFORMANCE SUMMARY:

  • FY 2026 consolidated sales grew by 9% year-on-year on the back of underlying volume growth of 6%,
  • Standalone business underlying volume grew by 6%, sales grew by 8% year-on-year
  • Indonesia sales de-grew by 2% year-on-year
  • Africa, USA, and Middle East sales grew 23% year-on-year
  • FY 2026 consolidated EBITDA* margins stood at 20.9%, growing 5% year-on-year.
  • FY 2026 consolidated net profit grew by 6% year-on-year (without exceptional items and one-offs)

*EBITDA incl. forex

MANAGING DIRECTOR AND CEO’S COMMENTS

Commenting on the business performance, Sudhir Sitapati, Managing Director, and CEO, GCPL, said: Q4 FY2026 has been a quarter of strong, broad-based performance for Godrej Consumer Products Limited, fully aligned with our expectations and strategic priorities. The quarter ends a year in which the consistent execution of our Goodness Manifesto, our focus on category development and our discipline on cost have come together to deliver healthy, profitable growth across our portfolio.

At a consolidated level, Revenues grew 11% in INR terms, on the back of 6% underlying volume growth and 7% growth on a constant currency basis. EBITDA grew by 10%, with operating margin at 21.7%. Net profit after tax grew by 10% on a reported, reflecting the underlying quality of earnings being delivered by the business.

Our Standalone India business delivered an excellent quarter, driven by 8% underlying volume growth and 10% sales growth. EBITDA grew 18%, with margins at a healthy 24.7%, supported by disciplined cost management, calibrated pricing actions and improved operating leverage. Within the Standalone business, Home Care delivered 12% value growth, with continued strong momentum across Household Insecticides, Air Fresheners and Fabric Care, and consistent market share gains in our key categories. Personal Care grew 3%, with Personal Wash continued gaining market share on the back of strong in- market execution Perfumes and Deodorants delivered strong double-digit growth led by Perfumes, with KS99 now scaled pan-India.

Turning to our international portfolio, in Indonesia, the pricing pressures we have been calling out over the last several quarters have now largely bottomed out, and we are seeing increasingly clear early signs of stabilisation. The business delivered 4%, underlying volume growth and 3% sales growth, and we continue to expect operating conditions to improve from FY2027 as the market normalizes.

Our Africa, USA and Middle East business delivered another strong quarter, with top-line growth of 20%. EBITDA grew 2%, reflecting a deliberate doubling of media spends behind our FMCG categories to build the long-term franchise; we believe this is the right investment to make as the geography enters its next phase of growth.

Our Latin America and Others business delivered 26% sales growth. EBITDA in this geography was impacted by certain one-time costs in the quarter; we expect this to normalize over the coming quarters.

Looking ahead, we enter FY2027 from a position of strength. Our India business is well placed to deliver continued, calibrated growth at normative EBITDA margins, supported by improving demand trends, a strengthening innovation pipeline and consistent in-market execution. In Indonesia, we expect a meaningful step-up in performance as pricing pressures abate; and our Africa, USA and Middle East business continues to deliver on its stated objective of strong revenue and profit growth over the medium term. As the year closes, our unwavering focus on category development, cost discipline and operational excellence continues to translate into improving performance. With strengthening demand trends, consistent portfolio actions and a clear strategic roadmap, we are increasingly confident in our ability to deliver sustained, profitable growth and create long-term value for all our stakeholders.